Cargando…
Evaluation of fluid responsiveness during COVID-19 pandemic: what are the remaining choices?
Non-protocolized fluid administration in critically ill patients, especially those with acute respiratory distress syndrome (ARDS), is associated with poor outcomes. Therefore, fluid administration in patients with Coronavirus disease (COVID-19) should be properly guided. Choice of an index to guide...
Autores principales: | Hasanin, Ahmed, Mostafa, Maha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246295/ https://www.ncbi.nlm.nih.gov/pubmed/32451626 http://dx.doi.org/10.1007/s00540-020-02801-y |
Ejemplares similares
-
Tocilizumab in patients with COVID-19: which patient, time, and dose?
por: Hasanin, Ahmed, et al.
Publicado: (2021) -
EEG during the COVID-19 pandemic: What remains the same and what is different
por: Sethi, Nitin K.
Publicado: (2020) -
Fluid responsiveness in acute circulatory failure
por: Hasanin, Ahmed
Publicado: (2015) -
COVID-19 Imaging: What We Know Now and What Remains Unknown
por: Kanne, Jeffrey P., et al.
Publicado: (2021) -
Validity of mini-fluid challenge for predicting fluid responsiveness following liver transplantation
por: Mukhtar, Ahmed, et al.
Publicado: (2019)